Viveve Medical (NASDAQ:VIVE) Sees Large Volume Increase

Viveve Medical Inc (NASDAQ:VIVE) shares saw an uptick in trading volume on Monday . 1,593,359 shares traded hands during mid-day trading, an increase of 420% from the previous session’s volume of 306,355 shares.The stock last traded at $0.86 and had previously closed at $0.84.

A number of equities research analysts recently commented on the company. ValuEngine lowered Viveve Medical from a “buy” rating to a “hold” rating in a research report on Saturday, November 23rd. Maxim Group restated a “hold” rating on shares of Viveve Medical in a report on Friday, August 9th. Finally, LADENBURG THALM/SH SH raised Viveve Medical from a “neutral” rating to a “buy” rating in a report on Tuesday. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and one has assigned a buy rating to the stock. Viveve Medical currently has a consensus rating of “Hold” and an average price target of $2.24.

The firm has a market capitalization of $1.25 million, a price-to-earnings ratio of -0.01 and a beta of -0.04. The firm’s 50-day moving average is $3.58 and its 200 day moving average is $1.67.

Viveve Medical (NASDAQ:VIVE) last released its quarterly earnings results on Thursday, November 7th. The company reported ($13.51) EPS for the quarter, beating analysts’ consensus estimates of ($16.00) by $2.49. The firm had revenue of $1.05 million for the quarter. Viveve Medical had a negative return on equity of 2,979.48% and a negative net margin of 429.71%. On average, equities analysts anticipate that Viveve Medical Inc will post -69 EPS for the current fiscal year.

In other news, major shareholder Goldman Sachs Group Inc bought 64,200 shares of Viveve Medical stock in a transaction dated Tuesday, September 24th. The stock was bought at an average cost of $5.76 per share, for a total transaction of $369,792.00. 5.20% of the stock is currently owned by insiders.

A hedge fund recently bought a new stake in Viveve Medical stock. FNY Investment Advisers LLC purchased a new position in Viveve Medical Inc (NASDAQ:VIVE) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 16,136 shares of the company’s stock, valued at approximately $71,000. FNY Investment Advisers LLC owned about 1.10% of Viveve Medical as of its most recent SEC filing. 32.96% of the stock is currently owned by institutional investors and hedge funds.

About Viveve Medical (NASDAQ:VIVE)

Viveve Medical, Inc designs, develops, manufactures, and markets medical devices for the non-invasive treatment of various post-partum conditions. The company offers Viveve System, a radio frequency generator, a reusable hand piece, and single-use treatment tip, as well as other consumable components.

Featured Story: What is the significance of a dead cat bounce?

Receive News & Ratings for Viveve Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viveve Medical and related companies with MarketBeat.com's FREE daily email newsletter.